BioCentury
ARTICLE | Clinical News

Sofosbuvir/velpatasvir/voxilaprevir: Phase III data

October 31, 2016 7:00 AM UTC

Top-line data from the open-label, international Phase III POLARIS-2 trial in 941 patients with chronic HCV genotypes 1-6 infection who were not previously treated with a direct-acting antiviral (DAA)...